These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 34838533)
1. IL-17A and IFN-γ are Up-regulated in CD4 and γδ T Cells in Active Behcet's Disease Patients. Abbasova V; Gül A; Saruhan-Direskeneli G Immunol Lett; 2022 Feb; 242():37-45. PubMed ID: 34838533 [TBL] [Abstract][Full Text] [Related]
2. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease. Sugi-Ikai N; Nakazawa M; Nakamura S; Ohno S; Minami M Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479 [TBL] [Abstract][Full Text] [Related]
3. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease. Shimizu J; Takai K; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Suzuki N Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240 [TBL] [Abstract][Full Text] [Related]
4. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease. Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558 [TBL] [Abstract][Full Text] [Related]
5. CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells. Haas JD; González FH; Schmitz S; Chennupati V; Föhse L; Kremmer E; Förster R; Prinz I Eur J Immunol; 2009 Dec; 39(12):3488-97. PubMed ID: 19830744 [TBL] [Abstract][Full Text] [Related]
6. Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis--influence of treatment with interferon-alpha2a. Amberger M; Groll S; Günaydin I; Deuter C; Vonthein R; Kötter I Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S52-7. PubMed ID: 17949552 [TBL] [Abstract][Full Text] [Related]
7. Expression of regulatory receptors on γδ T cells and their cytokine production in Behcet's disease. Parlakgul G; Guney E; Erer B; Kılıcaslan Z; Direskeneli H; Gul A; Saruhan-Direskeneli G Arthritis Res Ther; 2013 Jan; 15(1):R15. PubMed ID: 23336215 [TBL] [Abstract][Full Text] [Related]
8. Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A. Chi W; Yang P; Zhu X; Wang Y; Chen L; Huang X; Liu X Mol Vis; 2010 May; 16():880-6. PubMed ID: 20508866 [TBL] [Abstract][Full Text] [Related]
9. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease. Aktas Cetin E; Cosan F; Cefle A; Deniz G Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963 [TBL] [Abstract][Full Text] [Related]
11. Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Freysdottir J; Lau S; Fortune F Clin Exp Immunol; 1999 Dec; 118(3):451-7. PubMed ID: 10594567 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis. Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236 [TBL] [Abstract][Full Text] [Related]
13. Production of interferon gamma and interleukin 17A in chicken T-cell subpopulations hallmarks the stimulation with live, irradiated and killed avian pathogenic Escherichia coli. Bagheri S; Paudel S; Wijewardana V; Kangethe RT; Cattoli G; Hess M; Liebhart D; Mitra T Dev Comp Immunol; 2022 Aug; 133():104408. PubMed ID: 35390358 [TBL] [Abstract][Full Text] [Related]
14. Cytokine profile in Behçet's disease patients. Relationship with disease activity. Hamzaoui K; Hamzaoui A; Guemira F; Bessioud M; Hamza M; Ayed K Scand J Rheumatol; 2002; 31(4):205-10. PubMed ID: 12369651 [TBL] [Abstract][Full Text] [Related]
15. Upregulated IRAK1 and IRAK4 promoting the production of IFN-γ and IL-17 in Behcet's disease. Sun M; Yang P; Yang Y; Ye J Int Ophthalmol; 2018 Oct; 38(5):1947-1953. PubMed ID: 28780618 [TBL] [Abstract][Full Text] [Related]
16. Proinflammatory cytokines and C-reactive protein in uveitis associated with Behçet's disease. Mesquida M; Molins B; Llorenç V; Sainz de la Maza M; Hernandez MV; Espinosa G; Adán A Mediators Inflamm; 2014; 2014():396204. PubMed ID: 24994946 [TBL] [Abstract][Full Text] [Related]
17. CD4⁺ T cells from behcet patients produce high levels of IL-17. Chi W; Zhou S; Yang P; Chen L Eye Sci; 2011 Jun; 26(2):65-9. PubMed ID: 21692201 [TBL] [Abstract][Full Text] [Related]
18. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease. Treusch M; Vonthein R; Baur M; Günaydin I; Koch S; Stübiger N; Eckstein AK; Peter HH; Ness T; Zierhut M; Kötter I Rheumatology (Oxford); 2004 Oct; 43(10):1275-82. PubMed ID: 15252211 [TBL] [Abstract][Full Text] [Related]
19. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis. Takeuchi M; Usui Y; Okunuki Y; Zhang L; Ma J; Yamakawa N; Hattori T; Kezuka T; Sakai J; Goto H Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3067-75. PubMed ID: 20089879 [TBL] [Abstract][Full Text] [Related]
20. Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51. Yasuoka H; Yamaguchi Y; Mizuki N; Nishida T; Kawakami Y; Kuwana M Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S59-63. PubMed ID: 19026117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]